Ensign Group [ENSG] vs Encompass Health [EHC] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Ensign Group, Inc. wins in 4 metrics, Encompass Health Corporation wins in 17 metrics, with 0 ties. Encompass Health Corporation appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ensign Group, Inc. | Encompass Health Corporation | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 32.78 | 18.52 | Encompass Health Corporation |
| Price-to-Book Ratio | 4.95 | 4.21 | Encompass Health Corporation |
| Debt-to-Equity Ratio | 98.70 | 82.85 | Encompass Health Corporation |
| PEG Ratio | 1.76 | 0.89 | Encompass Health Corporation |
| EV/EBITDA | 24.01 | 9.92 | Encompass Health Corporation |
| Profit Margin (TTM) | 6.80% | 9.54% | Encompass Health Corporation |
| Operating Margin (TTM) | 9.10% | 18.35% | Encompass Health Corporation |
| EBITDA Margin (TTM) | 9.10% | 18.35% | Encompass Health Corporation |
| Return on Equity | 16.90% | 24.82% | Encompass Health Corporation |
| Return on Assets (TTM) | 5.25% | 9.66% | Encompass Health Corporation |
| Free Cash Flow (TTM) | $370.71M | $439.20M | Encompass Health Corporation |
| Dividend Yield | 0.16% | 0.68% | Encompass Health Corporation |
| 1-Year Return | 13.85% | -12.45% | Ensign Group, Inc. |
| Price-to-Sales Ratio (TTM) | 2.21 | 1.74 | Encompass Health Corporation |
| Enterprise Value | $12.70B | $13.70B | Encompass Health Corporation |
| EV/Revenue Ratio | 2.51 | 2.31 | Encompass Health Corporation |
| Gross Profit Margin (TTM) | 16.34% | 95.82% | Encompass Health Corporation |
| Revenue per Share (TTM) | $88 | $59 | Ensign Group, Inc. |
| Earnings per Share (Diluted) | $5.85 | $5.55 | Ensign Group, Inc. |
| Beta (Stock Volatility) | 0.82 | 0.60 | Encompass Health Corporation |
| Short % of Float | 2.93% | 3.81% | Ensign Group, Inc. |
Ensign Group, Inc. vs Encompass Health Corporation Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ensign Group, Inc. | 0.43% | -3.89% | -8.97% | -23.22% | -8.52% | -4.72% |
| Encompass Health Corporation | -1.15% | -3.20% | -4.77% | -6.02% | -10.81% | -4.53% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ensign Group, Inc. | 13.85% | 83.00% | 102.89% | 788.92% | 2,168.61% | 3,969.17% |
| Encompass Health Corporation | -12.45% | 68.71% | 62.37% | 226.70% | 397.88% | 511.85% |
Performance & Financial Health Analysis: Ensign Group, Inc. vs Encompass Health Corporation
| Metric | ENSG | EHC |
|---|---|---|
| Market Information | ||
| Market Cap | $11.06B | $10.25B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 313,976 | 858,260 |
| 90 Day Avg. Volume | 348,765 | 939,637 |
| Last Close | $165.71 | $101.55 |
| 52 Week Range | $134.79 - $218.00 | $92.77 - $127.99 |
| % from 52W High | -23.99% | -20.66% |
| All-Time High | $218.00 (Mar 02, 2026) | $127.99 (Oct 24, 2025) |
| % from All-Time High | -23.99% | -20.66% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.20% | 0.10% |
| Quarterly Earnings Growth | 0.20% | 0.21% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | 0.10% |
| Operating Margin (TTM) | 0.09% | 0.18% |
| Return on Equity (TTM) | 0.17% | 0.25% |
| Debt to Equity (MRQ) | 98.70 | 82.85 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $38.71 | $24.38 |
| Cash per Share (MRQ) | $9.92 | $0.73 |
| Operating Cash Flow (TTM) | $564.27M | $1.18B |
| Levered Free Cash Flow (TTM) | $281.25M | $296.79M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.16% | 0.68% |
| Last 12-Month Dividend | $0.32 | $0.72 |
Valuation & Enterprise Metrics Analysis: Ensign Group, Inc. vs Encompass Health Corporation
| Metric | ENSG (Apr 24, 2026) | EHC (Apr 23, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 32.78 | 18.52 |
| Forward P/E | 23.27 | 15.86 |
| PEG Ratio | 1.76 | 0.89 |
| Price to Sales (TTM) | 2.21 | 1.74 |
| Price to Book (MRQ) | 4.95 | 4.21 |
| Market Capitalization | ||
| Market Capitalization | $11.06B | $10.25B |
| Enterprise Value | $12.70B | $13.70B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.51 | 2.31 |
| Enterprise to EBITDA | 24.01 | 9.92 |
| Risk & Other Metrics | ||
| Beta | 0.82 | 0.60 |
| Book Value per Share (MRQ) | $38.71 | $24.38 |
Financial Statements Comparison: Ensign Group, Inc. vs Encompass Health Corporation
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ENSG (2025) | EHC (2025) |
|---|---|---|
| Revenue/Sales | 5.06B | 5.94B |
| Cost of Goods Sold | 4.26B | 254.40M |
| COGS % of Revenue | 84.2% | 4.3% |
| Gross Profit | 799.45M | 5.68B |
| Gross Margin | 15.8% | 95.7% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 425.31M | 1.05B |
| Operating Margin | 8.4% | 17.7% |
| EBITDA | 567.94M | 1.40B |
| EBITDA Margin | 11.2% | 23.7% |
| Pre-Tax Income | 455.62M | 953.00M |
| Pre-Tax Income % of Revenue | 9.0% | 16.1% |
| Income Tax | 111.36M | 192.90M |
| Income Tax % of Revenue | 2.2% | 3.3% |
| Net Income (Profit) | 344.26M | 759.10M |
| Profit Margin | 6.8% | 12.8% |
Balance Sheet & Liquidity Metrics
| Metric | ENSG (2025) | EHC (2025) |
|---|---|---|
| Cash & Equivalents | 503.88M | 72.20M |
| Total Current Assets | 1.27B | 905.90M |
| Total Current Assets % of Revenue | 25.2% | 15.3% |
| Total Current Liabilities | 894.35M | 836.40M |
| Total Current Liabilities % of Revenue | 17.7% | 14.1% |
| Long-Term Debt | 2.09B | 2.64B |
| Long-Term Debt % of Revenue | 41.3% | 44.5% |
| Total Shareholders Equity | 2.23B | 3.28B |
| Retained Earnings | 1.76B | 1.29B |
| Retained Earnings % of Revenue | 34.7% | 21.7% |
| Property, Plant & Equipment | 2.58B | 212.60M |
Cash Flow Statement Comparison
| Metric | ENSG (2025) | EHC (2025) |
|---|---|---|
| Operating Cash Flow | 409.74M | 1.19B |
| Operating Cash Flow % of Revenue | 8.1% | 20.1% |
| Capital Expenditures | -193.56M | -736.40M |
| Free Cash Flow | 370.71M | 439.20M |
| FCF Margin | 7.3% | 7.4% |
| Debt Repayment | -4.09M | -239.00M |
| Common Stock Repurchase | -21.43M | -158.00M |
Short Interest & Institutional Ownership Analysis
| Metric | ENSG | EHC |
|---|---|---|
| Shares Short | 1.44M | 3.36M |
| Short Ratio | 4.15 | 3.73 |
| Short % of Float | 2.93% | 3.81% |
| Shares Outstanding | 58.09M | 100.00M |
| Float Shares | 55.59M | 98.16M |
| % Held by Insiders | 3.54% | 1.05% |
| % Held by Institutions | 93.84% | 102.10% |
| % Held by Public | 2.62% | -3.15% |
Dividend Analysis & Yield Comparison: Ensign Group, Inc. vs Encompass Health Corporation
| Metric | ENSG | EHC |
|---|---|---|
| Last 12-Month Dividend | $0.32 | $0.72 |
| Last 12-Month Dividend Yield | 0.16% | 0.68% |
| 3-Year Avg Annual Dividend | $0.27 | $0.65 |
| 3-Year Avg Dividend Yield | 0.05% | 0.19% |
| 3-Year Total Dividends | $0.80 | $1.96 |
| Ex-Dividend Date | Mar 31, 2026 | Jan 02, 2026 |